2023 International Congress Archives - Page 174 of 186

Caffeine Intake Interacts with Gene Variants in Parkinson’s disease

E. Tan, Y. Ong, X. Deng, H. Li, D. Heng, K. Narasimhalu, L. Chan, P. Kumar, W. Au, P. Ratnagopal, L. Tan (Singapore, Singapore)
Calcium phenotype in cellular models of VPS13A disease

E. Fischer, K. Peikert, A. Spranger, H. Glaß, D. Großmann, A. Hermann (Rostock, Germany)
Can a global measure of cognition be used to inform balance interventions in Parkinson’s disease?

N. Burt, K. Arabian, S. Parrott, R. Gallagher (Old Westbury, USA)
Can a single-session of weight-shift training support people with Parkinson’s step from a freeze?

Y. Russo, P. Leveridge, J. Ye, Z. Wang, M. Wilson, A. Nieuwboer, S. Lamb, E. Kal, M. Norris, W. Young (Exeter, United Kingdom)
Can medicinal mushrooms help to stabilize or improve cognitive function in Parkinson’s patients with mild cognitive impairment?

S. Elsas (Arlesheim, Switzerland)
Can optical coherence tomography differentiate Parkinson’s disease from drug-induced parkinsonism?

SY. Kang, W. Suh, SU. Baek, JS. Oh, SY. Seo, JS. Kim, YM. Han, MS. Kim (Hwaseong, Republic of Korea)
Can radiofrequency lesion be better than DBS?

J. Brainer, P. Brainer, A. Brainer, P. Brainer (Recife, Brazil)
Can the Ohm’s law predict the amplitude of neurostimulation when adapting systems in deep brain stimulation?

C. Mota, R. Franco, C. Soares, M. Rosas (Porto, Portugal)
Can very early levodopa prevent self-injury in Lesch-Nyhan Disease?

J. Visser, O. Chorin, H. Jinnah (Nijmegen, Netherlands)
Cardio-respiratory fitness is associated with corticospinal excitability and motor learning in Parkinson’s Disease.

JC. Cristini, M. Beck, L. Rodrigues, B. De-Las-Heras, S. Steib, A. Dagher, J. Doyon, J. Lundbye-Jensen, M. Roig (Montreal, Canada)
Cardiovascular autonomic function in GBA-associated Parkinson’s disease: a cross-sectional study

T. de Santis, A. Cocco, P. Polverino, V. Polvere, EM. Valente, A. Albanese (Rozzano, Italy)
Cardiovascular complications in Parkinsonism: insights from Luxembourg Parkinson’s Study

S. Acharya, A. Lumley, Y. Devaux (Strassen, Luxembourg)
Caregiver burden in Parkinson disease: an updated scoping review

J. Corcoran, W. Aamodt, S. Seshadri, M. Mirham, A. Job, S. Lettenberger, B. Kluger (Rochester, USA)
Case of neuroferritinopathy with isolated dystonic leg cramps and normal neuroimaging

F. Mustafa, K. Sai Krishna, A. Das, A. Garg, A K. Srivastava (NEW DELHI, India)
Case report of 21 y/o. patient with 9 years of DBS in dystonia history and socioeconomic outcome.

B. Mukhammedaminov (Tashkent, Uzbekistan)
Case report of atypical PKAN expressed in late sixth-decade

S. Park (Daejeon, Republic of Korea)
Case report on heterozygous OPA3 gene mutation causing ataxia

J. Ng, T. Stiep (San Francisco, USA)
Case report on the use of a High Frequency Vibrotactile Stimulation and Cueing Device over 4 months in a patient with Parkinson’s Disease and refractory symptoms

A. Mackett (Cambridge, United Kingdom)
Case report- Cavernoma involving substantia nigra and nigrostriatal pathway as a rare cause of secondary parkinsonism with a 3 year follow up

S. Sathyanarayana, J. Pasquini, D. Ledingham, D. Mitra, N. Warren, N. Pavese (Newcastle Upon Tyne, United Kingdom)
Case Report: Supranuclear Palsy and Increased Intraocular Pressure in Normal Pressure Hydrocephalus

K. Young, M. Gates (Austell, USA)
Case series of Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT); different presentations and different treatment outcomes.

K. Methawasin, M. Jaisa-Aad (Nakhon Nayok, Thailand)
Case Study: Pitfalls of Commercial Genetic Testing for Huntington’s Disease

L. Fanty, J. Bravo, S. Corrigan, M. Maczis, L. Kugelmann, A. Wagle Shukla, M. Farrer, N. Mcfarland (Gainesville, USA)
Caveats regarding a family with PD and LRRK2 mutations

P. Ferreira, A. Ferreira, D. Fitas, S. Moreira, M. Calejo (Senhora da Hora, Portugal)
CBS presenting rapidly progressive anterior operculum syndrome with suggested background pathology of 4-repeat tauopathy by tau PET: A case report

K. Nakamura, Y. Kuroha, M. Hatakeyama, A. Kimura, Y. Nakamura, Y. Murakami, M. Watanabe, H. Igarashi, T. Takahashi, H. Shimada (Niigata city, Japan)
Cell-specific MAPT gene expression is preserved in tau cytopathologies in Progressive Supranuclear Palsy

S. Forrest, S. Lee, N. Nassir, V. Sackmann, I. Martinez-Valbuena1, J. Li, A. Ahmed, L. Ittner, A. Lang, M. Uddin, G. Kovacs (Toronto, Canada)
Cerebellar ataxia as primary manifestation of HIV: a rare etiological association

S. Jain, PN. Renjen, M. Gupta, P. Agarwal (Jaipur, India)
Cerebellar ataxia due to vitamin E deficiency

N. Stojiljkovic, S. Redko, F. Gupta, S. Kathiresu Nageshwaran, W. Tse (New York, USA)
Cerebellar ataxia in Hypomyelinating Leukodystrophies: A case series

J. Ganguly, J. Sinha, P. Basu, M. Tiwari, H. Kumar (Kolkata, India)
cerebellar cognitive affective syndrome is frequent in rfc1-related disorder

C. Lobo, NB. Santos, F. Lima, T. Rezende, PC. Matos, JL. Pedroso, O. Barsottini, W. Marques Jr, M. França Jr (Campinas, Brazil)
Cerebellar volumetry in SCA1, SCA3, SCA6, MSA-C, and SAOA

M. Ferreira, T. Schaprian, T. Klockgether, J. Faber (Bonn, Germany)
Cerebral Topography of [11C]-Flumazenil GABAA Receptor Expression in Parkinson’s Disease Fallers and Freezers

N. Bohnen, S. Roytman, J. Barr, K. Frey, P. Scott, R. Koeppe, P. Kanel (Ann Arbor, USA)
Cerebrospinal fluid biomarkers for diagnosis of Parkinson’s disease: a systematic review and network meta-analysis

SM. Li, YC. Zheng, C. Yang, JY. Wu, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)
Certification for advanced practice providers working in movement disorders expands access to quality expert and specialized care.

K. Papesh, B. Jones (Fort Collins, USA)
Cervical Dystonia as a post Wernicke’s Encephalopathy sequelae.

V. Khardenavis, A. Deshpande (Madurai, India)
Cervical Dystonia Patients with Psychiatric Disorders Show More Motor and Less Non-Motor Improvement after DBS surgery.

A. Weide, A. Khanom, Y. Wiggerts, A. Macerollo, M. Beudel, R. de Bie, Y. Namavar, R. Schuurman, J. Osman-Farah (Amsterdam, Netherlands)
Cervical dystonia with early onset as initial manifestation of adult-onset Huntington’s disease

I. šarac, H. šarac, F. Borovečki, N. Božina, J. Sertić, I. Ivek, L. Bagarić Krakan, Z. Krešić (Zagreb, Croatia)
Cervical Dystonic Tremor: A Characteristic Feature Of Ataxia With Vitamin E Deficiency

R. Zouari, C. Jeridi, R. Amouri, MZ. Saeid, F. Nabli, S. Ben Sassi (Tunis, Tunisia)
Challenges in patient-physician communication during limited time appointments in Parkinson’s disease

E. Zhunusova, C. Shambetova, A. Iliazova (Bishkek, Kyrgyzstan)
Challenges in the measurement of brain iron deposition in Parkinson’s disease in non-academic research settings.

B. Kashyap, K. Wyman-Chick, L. Hanson, S. Gustafson, S. Sherman, W. Frey, Ii, J. Johnson (St Paul, USA)
Challenges with oral anti-parkinsonian medications and opportunities with continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) for treatment of advanced Parkinson’s Disease (aPD)

J. Aldred, M. Soileau, C. Yan, T. Brion, A. Bellenger, J. Suh, C. O'Donnell, P. Kukreja, M. Facheris, A. Shewale, R. Kumar (Spokane, USA)
Change in quality of Life, depression, and lived experiences of women with Parkinson’s disease after deep drain stimulation

MS. Kim, S. Jo, KW. Park, SH. Lee, YS. Hwang, SJ. Chung (Seoul, Republic of Korea)
Changes in artistic style and Parkinson’s Disease

AM. Diezma Martín, G. Tabar Comellas, MI. Morales-Casado, DD. Garcia Melendez, JW. Ruiz Gómez, P. Quintana Castro, M. Ennazeh Elkhaili, D. Rivero Rodríguez, N. López Ariztegui (Toledo, Spain)
Changes in word fluency tasks and cognitive function before and after the COVID-19 epidemic in patients with Parkinson’s disease:PD.

M. Sagawa, K. Hasegawa, A. Kumon, M. Saruwatari (Kanagawa, Japan)
Characterisation of OFF-Time in Levodopa-Treated Parkinson’s Patients: A Post-hoc Analysis of an Exploratory Trial

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, B. Guimarães, J-F. Rocha (Lisbon, Portugal)
Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset

D. Bédard, F. Gaudette, F. Beaudry, P. Huot (Montreal, Canada)
Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.

K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, F. Tanaka (Yokohama, Japan)
Characteristics of Huntington disease in a north Indian cohort

D. Radhakrishnan, J. George, M. Faruq, R. Rajan, K. Kanojia, E. Arunmozhimaran, A. Das, A. Agarwal, A. Pandit, A. Srivastava (New Delhi, India)
Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale

T. Roushdy, E. Hamid, H. Salem, S. Reda, A. Shalash (cairo, Egypt)
Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device

J. Thompson, L. Hirt, D. Kern, A. Baumgartner (AURORA, USA)
Characterization of gait variability of early Parkinson’s disease and multiple system atrophy

M. Jecmenica Lukic, A. Tomic, I. Stankovic, V. Markovic, N. Kresojevic, N. Dragasevic, M. Svetel, I. Petrovic, S. Radovanovic, V. Kostic (Belgrade, Serbia)
Characterization of haemodynamic activity in resting-state networks associated with cognitive decline in PD: a fractal analysis approach

E. Fiorenzato, A. Antonini, L. Weis, R. Biundo, V. D’Onofrio, F. Ferreri, S. Moaveninejad, C. Porcaro (Padova, Italy)
Characterization of social cognition impairment in Huntington‘s disease

YF. Cheng, KC. Liu, TM. Yang, Y. Xiao, QR. Jiang, JX. Huang, SR. Zhang, XJ. Gu, JM. Burgunder, HF. Shang (Chengdu, China)
Characterization of the pathogenic α-Synuclein variant p.V15A in Parkinson´s disease

S H. Diaw, F. Buratti, L. Streubel-Gallasch, M. Borsche, M. Dulovic-Mahlow, C O. Fernández, J. Seeliger, I. Lenz, P. Seibler, C. Klein, N. Brüggemann, M. Zweckstetter, M. Vos, K. Lohmann (Lübeck, Germany)
Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study – results of the Belgian subgroup

V. van Iseghem, N. de Klippel, PH. Bourgeois, P. Bourgeois, T. Warlop, S. Dethy, E. Parmentier, D. Uyttersprot, K. Onuk, G. Garraux (Kortrijk, Belgium)
Characterizing Hospital Admissions in Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada

Y. Mahjoub, V. Bruno, S. Peters (Calgary, Canada)
Characterizing the neural response to electrical brain stimulation with spatiotemporal precision in mice.

J. Hickman, D. Denman (DENVER, USA)
Childhood-onset writer’s cramp evolving to generalised dystonia –a new mutation in KMT2B gene

M. Sequeira, M. Soares, J. Rosa (Lisboa, Portugal)
Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson’s disease: interim analysis of a pilot add-on, randomized, controlled, pragmatic clinical trial

S. Yuen, KK. Chua, L. Zhong, KW. Chan, C. Chan, CP. Ho, KL. Chan, E. Han, K. Pang, ZX. Lin, V. Mok, N. Cheung, AY. Lau, M. Li (Hong Kong, Hong Kong)
Chinese medicine pattern diagnostic criteria in clinical and epidemiological studies of Parkinson’s disease: a systematic review

CP. Ho, S. Yuen, C. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)
Chinese proprietary medicine as adjunct treatment for Parkinson’s disease: a systematic review and meta-analysis

S. Yuen, KK. Chua, SC. Chen, CP. Ho, C. Chan, M. Li (Hong Kong, Hong Kong)
Cholinergic deficits in Parkinson Disease

R. Miller, D. Dhavale, J. O’Shea, E. Franklin, N. Cairns, R. Perrin, M. Campbell, J. Perlmutter, P. Kotzbauer (St. Louis, USA)
Cholinergic subtyping in Parkinson disease: differential 2-year interval changes

N. Bohnen, S. Roytman, T. Brown, K. Frey, P. Scott, R. Koeppe, R. Albin, P. Kanel (Ann Arbor, USA)
Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)
Chorea as a clinical manifestation in adult-onset of metachromatic leukodystrophy

NT. Dragašević Mišković, A. Milovanović, M. Branković, I. Novaković, I. Petrović, A. Tomić Pešić, M. Svetel, VS. Kostić (Belgrade, Serbia)
Chorea following SARS-CoV-2 infection and vaccination: a systematic review

R. Bilavu, M. Simu, E. Rosca (Timișoara, Romania)
Chorea improvements over time with once-daily valbenazine treatment in adults with Huntington disease

E. Furr Stimming, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)
Choroidal changes in Parkinson’s disease: A longitudinal follow up study

P. Mailankody, R. Battu, PM. Pm, T. K, N. Kamble, R. Yadav, P. Pal (Bangalore, India)
Chromosomal Microarray Analysis for genetic evaluation of dystonia

A. Saini, R. Rajan, R. Mewara, B. Verma, N. Gupta, D. Radhakrishnan, E. A, A. Gupta, V. Vy, M. Singh, R. Bhatia, A. Srivastava, M. Srivastava (New Delhi, India)
Chronic pain and the polytrauma clinical triad are risk factors for prodromal PD

L. Neilson, N. Balba, J. Elliott, G. Scott, M. Heinricher, M. Lim (Portland, USA)
Chronic sensorimotor cortex sensing using permanently implanted subgaleal leads in a patient receiving deep brain stimulation for Parkinson’s disease

S. Sandoval-Pistorius, R. Fernandez-Gajardo, S. Cernera, P. Starr (San Francisco, USA)
Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

M. Andréasson, P. Svenningsson (Stockholm, Sweden)
Circadian rhythm and adaptive deep brain stimulation in essential tremor

J. Yu, L. Fanty, T. Stiep, J. Cagle, N. Geigel, A. Gunduz, C. de Hemptinne (Gainesville, USA)
Circuit-based targeting for closed-loop deep brain stimulation for Tourette Syndrome

C. Butson, A. Gunduz, K. Foote, E. Mahoney-Rafferty, J. Gomez, M. Hook, J. Cagle, G. Lowor, U. Suryadevara, D. Bowers, I. Malaty, W. Allen, M. Okun (Gainesville, USA)
Classification and genotype-phenotype relationships of GBA1 variants and Parkinson’s disease: MDSGene Systematic Review

T. Usnich, M. Rossi, S. Schaake, N. Schell, J. Böhm, N. Steffen, C. Krüger, R. Alcalay, K. Lohmann, C. Klein (Lübeck, Germany)
Classification of Obstructive Sleep Apnea based on Statistical Features of the RR Interval using the Support Vector Machine Algorithm

R. Fajar, E. Syafruddin, S. Putry (Sleman, Indonesia)
Clebopride-induced Rabbit Syndrome: A Case Report.

IA. Ortiz-Marroquin, E. Valdez-Rodriguez, V. Rodriguez-Martinez, D. Martinez-Ramirez (Monterrey, Mexico)
Clinal comprehensive Next-gen gene panel for Parkinson’s Disease

Z. Niu, E. Lauer, S. Roellinger, L. Hasadsri, O. Ross, R. Savica (Rochester, USA)
Clinic versus home dose optimization of apomorphine sublingual film in Parkinson’s Disease: cross-study comparison of safety

SH. Isaacson, J. Kassubek, R. Pahwa, E. Pappert, S. Wu, C. Denecke Muhr (Boca Raton, USA)
Clinical accuracy of Medtronic’s Percept built in longevity estimate algorithm following device exchange.

E. Hargreaves, D. Caputo, D. Dolce, R. Dipaola, S. Danish (Neptune, USA)
Clinical analysis of Levodopa/carbidopa intestinal gel infusion in advanced Parkinson’s disease. A single-center retrospective cohort study.

D. Rivero Rodriguez, G. Tabar Comellas, MI. Morales Casado, AM. Diezma Martin, D. Garcia Melendez, M. Ennazeh Elkhaili, N. López Ariztegui (Toledo, Spain)
Clinical and functional determinants of motor reserve in patients with de novo Parkinson’s disease

S. Prange, M. Hoenig, H. Theis, E. Metereau, S. Thobois, T. van Eimeren (Cologne, Germany)
Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia

S. Gorcenco, E. Kafantari, J. Wallenius, C. Karremo, E. Alinder, S. Dobloug, M. Landqvist Waldö, E. Englund, H. Ehrencrona, K. Wictorin, K. Karrman, A. Puschmann (Lund, Sweden)
Clinical and genetic characteristics of a cohort of 20 patients with confirmed biallelic pathogenic SPG7 mutations from the North West of England

R. Heartshorne, J. Proudfoot-Jones, A. Barakat, M. Bonello (Liverpool, United Kingdom)
Clinical and genetic profile of fifteen patients with PARK-PRKN: A largest single-center cohort from India.

V. Holla, S. Kamath, P. Phulpagar, N. Kamble, B. Muthusamy, R. Yadav, P. Pal (Bengaluru, India)
Clinical and molecular features of Tunisian patients with Biallelic mutations in Huntington’s Disease

H. Nehdi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)
Clinical and radiological characteristics of a cohort of seventy-one Multiple System Atrophy patients

G. Franco, G. Lazzeri, E. Bernardi, F. Arienti, A. Di Fonzo (Milan, Italy)
Clinical and radiological characteristics of elder patients of Parkinson’s disease with the onset age of more than 80 years old

M. Nomoto, H. Iwaki, R. Nonaka, N. Yano (Imabari, Ehime, Japan)
Clinical and radiological factors associated with mortality in Parkinson’s disease

G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, R. Luquin (Pamplona, Spain)
Clinical and radiological gender differences in Parkinson’s disease

G. Martí-Andrés, E. Prieto-Azcarate, CA. Espinoza-Vinces, M. Riverol, S. Meles, KL. Leenders, P. Tomse, M. Perovnik, M. Trost, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)
Clinical characteristics of patients with dementia with Lewy bodies followed in a movement disorder clinic

AS. Jakobsson, L. Salvesen, AM. Hejl (Copenhagen, Denmark)
Clinical characterization of Parkinson’s disease patients with LRRK2 mutation: Insights from a Portuguese reference center

JM. Alves, MR. Almeida, C. Machado, F. Moreira, A. Morgadinho (Coimbra, Portugal)
Clinical characterization of patients with functional movement disorders

Y. Guzman, A. Soto, T. Saldivar (Mexico City, Mexico)
Clinical correlates of olfactory dysfunction in Huntington’s disease

N. Rocha, J. Patino, S. Abdollah Zadegan, H. Coco, A. Liang, F. Ramirez, E. Furr Stimming (Houston, USA)
Clinical features and phenoconversion risk in women with isolated REM sleep behavior disorder

C. Alexandres, S. Mccarter, G. Tabatabai, L. Leclair-Visonneau, J. Feemster, T. Gossard, P. Timm, D. Sandness, J. Jagielski, E. Strainis, D. Carvalho, M. Junna, M. Lipford, J. Moore, M. Tippmann-Peikert, M. Silber, B. Boeve, E. ST. Louis (Rochester, USA)
Clinical implication of small vessel disease burden on deep brain stimulation outcome in Parkinson’s disease

J. Lee, S. Jo, S. Lee, MS. Kim, SJ. Chung (Seoul, Republic of Korea)
Clinical Improvement and drastic reduction of Equivalent Dose of Levodopa (LEDD) in an Advanced Parkinson’s Disease Patient after Levodopa/Entacapone/Carbidopa Intestinal Gel (LECIG) Treatment

G. Tabar Comellas, MI. Morales Casado, JC. Segundo-Rodríguez, N. Lopez Ariztegui (Toledo, Spain)
Clinical Phenotypes and Imaging Localization of Movement Disorders after Acute Stroke

E. Samra, T. Roushdy, A. Saeed, A. Mansour, A. Elbassiouny, A. Shalash (Kafr Elsheikh, Egypt)
Clinical practice feasibility of a wearable appcessory for quantitative evaluation of motor symptoms in Parkinson’s disease

A. Arrais, D. Dias, J. Silva Cunha, J. Massano, C. Soares (Porto, Portugal)
Clinical Prediction of GBA Carrier Status in Parkinson’s Disease

J. Greenberg, K. Astudillo, S. Frucht, A. Flinker, G. Riboldi (New York, USA)
Clinical presentation and evolution of isolated focal and segmental dystonia in adults – 20 years experience from a botulinum toxin clinic

A. Vijayaraghavan, D. Divya, S. Krishnan (Trivandrum, India)
Clinical Profile Of Drug-Induced Movement Disorders In Cipto Mangunkusumo Hospital, Indonesia

V. Sutanto, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)
Clinical progression in males and females with early treatment-naive Parkinson’s disease

T. Kassuba, B. Ribba, T. Simuni, K. Marek, A. Siderowf, L. Chahine, M. Picillo, P. Brundin, G. Pagano (Basel, Switzerland)
Clinical severity in Parkinson’s disease is determined by decline in cortical compensation

M. Johansson, I. Toni, R. Kessels, B. Bloem, R. Helmich (Nijmegen, Netherlands)
Clinical spectrum, imaging characteristics and care giver burden assessment of early onset non-dominant progressive cerebellar ataxias

R. Devaraj, P. Pal, N. M, RY. Yadav, M. Faruq, J. Saini, S. Hegde (Bangalore, India)
Clinical toolkits to improve conversations about Parkinson’s dementia

I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)
Clinical usefulness of tandem gait test for estimating gait and balance in de novo Parkinson’s disease

JS. Park, HT. Kim, SH. Lim (Busan, Republic of Korea)
Clinical-based diagnosis and self-reported Parkinson’s disease in a population-based sample in southern Brazil

G. Pereira, N. Soares, G. Marconi, C. Sangali, I. Pasuch, C. Bertocchi, N. Bruscato, J. Senger, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)
Clinical, radiological and genetic spectrum of fifteen cases of PLA2G6-Associated Neurodegeneration – A Single Centre Cohort from India

P. Pal, V. Holla, N. Sriram, R. Kumari, P. Phulpagar, S. Kamath, S. Prasad, N. Kamble, J. Saini, R. Mahale, M. Netravathi, H. Padmanabha, V. Gowda, R. Battu, A. Pandey, R. Yadav, B. Muthusamy (Bengaluru, India)
Clinico-genetic analysis of patients with Parkinson’s disease and GBA mutations from a tertiary care teaching centre in India

S. Kamath, V. Holla, P. Phulpagar, N. Kamble, R. Yadav, B. Muthusamy, PK. Pal (Bangalore, India)
Clinico-pathological correlations in atypical parkinsonism

R. Fumi, M. Theilmann Jensen, L. Wu, D. Vaughan, V. Chelban, Y. Goh, R. Real, A. Martinez Carrasco, E. Jabbari, A. Church, J. Coebergh, C. Kobylecki, U. Nath, M. Hu, A. Misbahuddin, J. Sharma, L. Massey, E. Capps, A. Robinson, F. Roncaroli, A. Lees, O. Ansorge, K. Allison, T. Warner, J. Rohrer, T. Revesz, Z. Jaunmuktane, J. Rowe, H. Houlden, H. Morris (London, United Kingdom)
Closed-loop gait improvement in Parkinson’s Disease

P. Kirsch, M. Helbig, S. Baudrexel, C. Kell (Frankfurt am Main, Germany)
Clozapine Therapy for Parkinson’s Disease Psychosis: A 21-Year Service Analysis

W. Woods, T. Payne, N. Hoyle, O. Bandmann (Sheffield, United Kingdom)
Co-designing Digital Technologies to improve Clinical Care in People with Parkinson’s Disease

M. Monje, S. Grosjean, M. Srp, L. Antunes, R. Bouca-Machado, R. Cacho, S. Rodriguez, J. Inocentes, T. Lynch, A. Tsakanika, D. Fotiadis, G. Rigas, E. Ruzicka, J. Ferreira, A. Antonini, N. Malpica, T. Mestre, A. Sánchez-Ferro (Chicago, USA)
Cognition evaluation in patients following focused ultrasound thalamotomy for tremor

I. Shifrin Senderova, I. Schlesinger, M. Nassar, A. Sinai, R. Haddad, I. Erikh, L. Shornikov, M. Constantinescu (Haifa, Israel)
Cognitive assessment of Parkinson’s disease carriers of the novel p.A30G mutation in the SNCA gene

C. Koros, I. Alefanti, AM. Simitsi, A. Bougea, N. Papagiannakis, R. Antonelou, C. Kartanou, M. Bozi, I. Pachi, S. Varvaresos, A. Zahou, E. Stanitsa, M. Kodounis, M. Maniati, M. Panas, G. Paraskevas, S. Papageorgiou, C. Potagas, G. Karadima, G. Koutsis, L. Stefanis (Athens, Greece)
Cognitive flexibility associates with atrophy and disrupted connectivity of the cognitive cerebellum in degenerative cerebellar ataxia

JH. Shin, HJ. Kim, SY. Lee, WT. Yoon, SW. Park, SM. Park, D. Yoo, JY. Lee (Seoul, Republic of Korea)
Cognitive function in Parkinson’s disease: associations with perivascular space in basal ganglia

L. Luo, L. Li, Y. Yin, R. Ren, Y. Yang (Kunming, China)
Cognitive Interference in Postural Control as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders.

R. Lloyd, C. Fearon, R. Reilly (Dublin, Ireland)
Cognitive overlap between Parkinson disease (PD) and Alzheimer’s disease (AD) is associated with plasma biomarkers and their impact on regional cortical thickness (CT): An ONDRI Study

M. Masellis, G. Coughlan, P. Zhukovsky, E. Sanchez, D. Munoz, R. Buckley, T. Steeves, P. Mclaughlin, D. Grimes, M. Jog, C. Marras, H. Zetterberg, H. Kvartsberg, M. Binns, SE. Black, AE. Lang (Toronto, Canada)
Cognitive profile of essential tremor patients: Beyond the cerebellar cognitive affective syndrome

A. Nasri, A. Rekik, S. Mrabet, Y. Abida, A. Souissi, A. Gharbi, I. Kacem, A. Gargouri, R. Gouider (Tunis, Tunisia)
Cognitive underside of Parkinson’s Disease: A working memory updating failure in freezing of gait

M. Mandal, A. Khan (PUNE, India)
Combination COMT inhibitor with Levodopa reduces consumption of vitamin B6

D. Kamiyama, N. Nishikawa, S. Ueno, C. Abe, T. Hatano, N. Hattori (Tokyo, Japan)
Combination of clinical and gait measures to classify fallers and non-fallers in Parkinson’s disease

H. Araújo, S. Smaili, J. Das, R. Morris, S. Stuart, R. Vitorio (Londrina, Brazil)
Combined approach in the diagnostic of Parkinson’s disease

D D. Pokhabov, V. Abramov, T. Subbotina, D V. Pokhabov (Krasnoyarsk, Russian Federation)
Combined effect of polygenic background and GBA Pathogenic variants in Parkinson’s disease risk

Z. Landoulsi, E. Hassanin, S. Pachchek, DB. Bobbili, P. May (Esch-sur-Alzette, Luxembourg)
Combined GWAS of Dementia with Lewy Bodies, REM-Sleep Behavior Disorder, Parkinson’s Disease and Alzheimer’s Disease

P. Saini, E. Yu, L. Krohn, Z. Gan-Or (Montreal, Canada)
Common oscillatory patterns between Parkinson’s disease and heroin dependent patients: a resting-state EEG study

D. Benis, V. Fleury, P. Krack (Geneva, Switzerland)
Comorbid Functional Neurologic disorders in patients with Parkinson.s disease in a rural hospital in Western part of India

S. Desai, D. Desai (Anand, India)
Comparative Analysis of Stepwise Unilateral and Simultaneous Bilateral Deep Brain Stimulator Electrode Placement for Parkinosn’s Disease

K. Yekuno, M. Marsans, C. Drolet, J. Roberts, S. Srivastal, F. Farrokhi (Seattle, USA)
Comparative Assessment of Gait and Balance in Patients with Parkinson’s Disease and Normal Pressure Hydrocephalus

K. Akar, H. Youssef, ö. öztop çakmak, M. Samancı, S. Ertan, A. Vural (Istanbul, Turkey)
Comparative Effects of Medical Treatment and Tension Deactivation Via Electromyography Biofeedback Intervention to Improve Maximum Mouth Opening in Individuals With Bruxism

MYA. Amine, U. El-Dakrory (Giza, Egypt)
Comparative efficacy of pharmacological cognitive treatments in Parkinson’s disease and Dementia of Lewy Bodies: systemic review & network meta-analysis

F. Al Hajraf, S. Manohar, M. Hu (Oxford, United Kingdom)
Comparative study of Non-Motor Symptoms and it’s correlation with Quality of Life in Parkinson’s disease and Atypical Parkinsonism

D. Joshi, A. Kumar, M. Tapadia (varanasi, India)
Comparative whole transcriptome analysis of human and mice models of Parkinson’s disease bearing defective glucocerebrosidase activity revealed alteration of expression profile of genes involved in the autophagy

A. Bezrukova, K. Basharova, M. Rudenok, M. Nikolaev, A. Kopytova, I. Miliukhina, A. Emelyanov, M. Shadrina, P. Slominsky, S. Pchelina, T. Usenko (Gatchina, Russian Federation)
Comparing Change in Motor and ADL Rating Scales after DBS in Parkinson’s disease, Dystonia and Tremor

Y. Wiggerts, E. Markidis, A. Weide, M. Bot, V. Odekerken, P. Munckhof, J. Dijk, Y. Namavar, R. Schuurman, R. Bie, M. Beudel (Amsterdam, Netherlands)
Comparing neuromelanin intensity estimation techniques for Parkinson’s disease image analysis

V. Madge, V. Fonov, A. Bailey, A. Dagher, E. Fon, R. Postuma, DL. Collins (Montréal, Canada)
Comparing the Connectivity of Thalamic Deep Brain Stimulation Sites in ET and ET Plus Syndrome

C. Yu, D. Lench, G. Revuelta (Charleston, USA)
Comparing the outcome under General Anaesthesia (GA) and Monitored Anesthesia Care (MAC) of Subthalamic Nucleus (STN) – Deep Brain Stimulation (DBS) Surgery for Parkinson’s Disease (PD) in Hong Kong – A single center experience

C. Lau, C. Zhu, V. Tang, A. Chan, K. Ma, P. Kan, A. Ng, J. Yeung, L. Cheung, V. Hui, D. Chan, D. Chan, W. Poon, V. Mok (Hong Kong, Hong Kong)
Comparision of objective Parkinson’s disease monitoring systems and the interpretations of results

G. Kilincalp, F. Grahn, H. Sabir, D. von Below, A. Jeppsson, A. Sjöström, F. Bergquist (Gothenburg, Sweden)
Comparison in the disability level according to WHODAS 2 between people living with Early and Late Onset Parkinson’s Disease

M E. Pimentel Piemonte, K. Costa Nobrega, I. Silva Nascimento, B. Antunes Souza, I. Carneiro Barone, G. Checchio, V. Pereira Ponciano, C. Cerveira Paula, A. Nunes Possani, N. Cardos Penha (Sao Paulo, Brazil)
Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson’s disease: A Systematic Review and Network Meta-Analysis

SM. Li, YC. Zheng, C. Yang, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)
Comparison of cognitive , affective and autonomic functions in parkinson’s disease patients with and without freezing of gait and its correlation with PET/CT

K. Harisankar, S. Mehta, R. Kumar, M. Mohanty, S. Singh, N. Balaini, V. Lal (CHANDIGARH, India)
Comparison of original and revised versions of the University of Pennsylvania Smell Identification Test

M. Brumm, K. Pierz, W. Aamodt, C. Gochanour, R. Kurth, C. Coffey, T. Foroud, E. Brown, R. Doty, T. Simuni, C. Tanner, K. Marek, A. Siderowf (Iowa City, USA)
Comparison of the MIBG uptake in the major salivary glands between progressive supranuclear palsy/corticobasal syndrome and Parkinson’s disease

J. Ebina, M. Shibukawa, H. Morioka, J. Nagasawa, M. Yanagihashi, T. Hirayama, N. Ishii, S. Mizumura, S. Orimo, O. Kano (Tokyo, Japan)
Complex movement disorder presentations of autoimmune encephalitis – recovery at 4 weeks versus 4 years

L. Jaffe (Honolulu, USA)
Compliance with national and international guidelines in the treatment of non-motor symptoms in late stage Parkinson’s disease

K. Rosqvist, P. Odin (Lund, Sweden)
Computerized assessment of Handwriting in Parkinson’s Disease Before and After Dopaminergic Medication

L. Diaz-Feliz, P. Sanz-Cartagena, M. Faundez-Zanuy, J. Arbelo-Gonzalez, P. Garcia-Ruiz (Las Palmas, Spain)
Computerized cognitive training in advanced Parkinson’s disease: preliminary feasibility data of an ongoing randomized controlled trial

P. Olgemöller, E. Kalbe, C. Hennen, M. Barbe, M. Hellmich, AK. Folkerts (Cologne, Germany)
Concealment of Parkinson’s Disease: Prevalence and Impact on Health and Quality of Life

G. Yogev-Seligmann, B. Naamneh Abuelhija, M. Giveon, M. Meir Kestenbaum, M. Kafri (Haifa, Israel)
Concordant RNA patterns in Parkinson’s disease brain and peripheral blood.

K. Irmady, C. Hale, J. Fak, R. Qadri, T. Carroll, S. Przedborski, R. Darnell, S. Simelane (NEW YORK, USA)
Connectivity Profile for Deep Brain Stimulation in Early-Stage Parkinson’s Disease

M. Hacker, N. Rajamani, C. Neudorfer, B. Hollunder, S. Oxenford, N. Li, A. Sternberg, T. Davis, P. Konrad, A. Horn, D. Charles (Nashville, USA)
Connectomic DBS informed multifocal transcranial direct current stimulation (tDCS) in Parkinson’s Disease: a crossover double blinded study

L L. Goede, S. Oxenford, D. Kroneberg, G M. Meyer, N. Rajamani, C. Neudorfer, P. Krause, R. Lofredi, M D. Fox, A A. Kühn, A. Horn (Berlin, Germany)
Connectomics of Chronic VIM vs Rescue VIM/VO Deep Brain Stimulation in Essential Tremor

V. Chandra, J. Wong, J. Hilliard, K. Foote, A. Fusco, Y. Mekri (Gainesville, USA)
Consanguinity is the key player in complexity of Mendelian form of neurodegeneration with brain iron accumulation in Pakistan

SHB. Rehman (Bannu, Pakistan)
Consideration of age and initial putaminal rim segment in distinguishing multiple system atrophy parkinsonian type

W. Lee (Seoul, Republic of Korea)
Constipation in Parkinson’s disease, a common problem with rare but serious complications

S. Lopes, S. Marques, A. Ferreira, S. Varanda, AM. Rodrigues (Braga, Portugal)
Contactless assessment of rigidity in Parkinson’s disease using machine vision and machine learning

X. Zhu, W. Shi, Y. Ling, N. Luo, Q. Yin, Y. Zhang, A. Zhao, G. Ye, H. Zhou, J. Pan, L. Zhou, L. Cao, P. Huang, P. Zhang, Z. Chen, C. Chen, S. Lin, J. Zhao, K. Ren, Y. Tan, J. Liu (Shanghai, China)
Continuity and presence of side effects of continuous subcutaneous apomorphine infusion and levodopa-carbidopa intestinal gel infusion in advanced Parkinson’s disease, in a movement disorder unit in Spain

I. Muro Garcia, J. Alonso Maroto, B. Gonzalez Garcia, E. Carabajal Pendon, E. Casas, L. Lopez Manzanares (Madrid, Spain)
Continuous algorithmic insights into PD motor symptoms and individual treatment response

M. Sander, FMJ. Pfister, G. Höglinger, J. Levin, A. Ceballos-Baumann, UM. Fietzek (Munich, Germany)
Continuous estimation of Parkinson’s on-off states using wearable devices

A. Arnold, T. Jansen, R. Gilron, N. Cottone, J. Sayaan, W. Chen (San Francisco, USA)
Continuous subcutaneous foslevodopa/foscarbidopa: final results from a phase 3, open-label study

J. Aldred, A. Amelin, A. Antonini, B. Bergmans, F. Bergquist, M. Bouchard, K. Budur, C. Carroll, K. Chaudhuri, S. Criswell, E. Danielsen, E. Freire Alvarez, F. Gandor, J. Jia, T. Kimber, H. Mochizuki, W. Robieson, A. Spiegel, D. Standaert, S. Talapala, M. Facheris, V. Fung (Spokane, USA)
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for Parkinson’s disease: Three-year data from the open-label BeyoND study

W. Poewe, A. Ellenbogen, F. Stocchi, L. Adar, L. Salin, R. Case, T. Yardeni, N. Giladi (Innsbruck, Austria)
Continuous subcutaneous levodopa/carbidopa infusion with ND0612 for patients with Parkinson’s disease and motor fluctuations: Results from the Phase 3 randomized, active-controlled BouNDless study

O. Rascol, A. Albanese, A. Ellenbogen, J. Ferreira, N. Giladi, T. Gurevich, S. Hassin-Baer, J. Hernandez-Vara, S. Isaacson, K. Kieburtz, P. Lewitt, L. Lopez-Manzanares, CW. Olanow, R. Pahwa, W. Poewe, H. Sarva, F. Stocchi, T. Yardeni, L. Adar, L. Salin, N. Lopes, N. Sasson, R. Case, A. Espay (Toulouse, France)
Contribution of MRI and machine learning approaches to the diagnosis of patients with early-stage parkinsonism in a situation of clinical uncertainty

L. Chougar, A. Faucher, J. Faouzi, FX. Lejeune, F. Cormier, M. Vidailhet, O. Colliot, S. Lehericy, D. Grabli, B. Degos (PARIS, France)
Controlled-release zolpidem improves freezing of gait and levodopa-induced dyskinesias in a patient with Parkinson’s disease.

P. Barbosa, E. Fonoff, MG. Ghilardi (Sao Paulo, Brazil)
Conventional anti-epileptic drugs used in North Sea Progressive Myoclonus Epilepsy revisited in a Drosophila model

S. Polet, R. Lambrechts, M. de Koning-Tijssen, O. Sibon, T. de Koning, J. Gorter (Groningen, Netherlands)
Coping strategies in people with Parkinson disease (PwP)

M A. Bacigalupe, D. Merino (La Plata, Argentina)
COPS: Continuous Observation of Parkinsonian Symptoms – A prospective data acquisition study using wearable accelerometery

T. Nesser, T. Dembek, C. Hennen, V. Stopic, M. Barbe (Cologne, Germany)
Correlates of gait impairment in parkinson’s disease

E. Abdeldayem, A. Shalash (Cairo, Egypt)
Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)
Correlation between fatigue, sleep dysfunction and health-related quality of life in Parkinson’s disease patients

EL. Ungureanu, S. Berzunțeanu, ș. Diaconu, A. Zârnoveanu, T. Drăgan, B. Ciocănescu, R. Filip, N. Enache, C. Falup-Pecurariu (Brasov, Romania)
Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease

O. Gavriliuc, L. Rotaru, M. Gavriliuc, A. Caldarov (Chisinau, Republic of Moldova)
Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson’s disease

Y. Zhu, X. Yang, H. Ren, A. Pang (Kunming, China)
Correlation between Motor Sections of UMSARS and MDS-UPDRS

S. Castillo-Torres, A. Ferreirós, M. Merello (Buenos Aires, Argentina)
Correlation between neurological phenotype, neuroimaging and clinical outcome in a single centre Wilson disease cohort.

J. Moura, C. Pinto, P. Freixo, C. Ramos, E. Silva, F. Nery, J. Gandara, V. Lopes, S. Ferreira, J. Presa, J. Castro Ferreira, H. Pessegueiro, M. Magalhães (Porto, Portugal)
Correlation between oculometric measures, disease severity, and clinical assessment in patients with Parkinson’s disease

J. Reiner, L. Franken, E. Raveh, I. Rosset, R. Kreitman, E. Ben-Ami, R. Djaldetti (Petah Tikva, Israel)
Correlation between rem sleep disorders and neurocognitive defects in patients with parkinson´s disease

M. Castillo, A. Mariñez, J. Duran, I. Joga, A. Morales (santo domingo, Dominican Republic)
Correlation between Striatal degeneration and Cerebellar fiber alterations of Parkinson’s disease

A. Shindo, T. Ogawa, T. Hatano, S. Ueno, W. Sako, K. Kamagata, A. Christina, H. Amano-Takeshige, W. Uchida, G. Oyama, A. Umemura, H. Iwamuro, M. Ito, A. Nakanishi, K. Murakami, S. Aoki, N. Hattori (Bunkyo-ku, Tokyo, Japan)
Correlation of clinical profile of Parkinsonism with molecular imaging

S. Lavania, A. Pattojoshi, AH. Khan (Agra, India)
Correlation of Functional Motor Assessments Used at Parkinson’s disease by Physiotherapists in Clinical Practice

APC. Loureiro, B. Yamaguchi, VL. Israel (Curitiba, Brazil)
Correlations between bradykinesia and acoustic speech variables in advanced Parkinson’s Disease

F. Cavallieri, G. Di Rauso, A. Gessani, C. Budriesi, V. Fioravanti, S. Contardi, E. Menozzi, S. Pinto, E. Moro, F. Antonelli, F. Valzania (Reggio Emilia, Italy)
Cortical Control of Gait and Balance During Single and Dual Tasks in Huntington’s Disease: an fNIRS study

J. O'Keefe, N. Purcell, S. Stuart, R. Vitorio, B. Ouyang, D. Hall (Chicago, USA)
Cortical excitability of sensorimotor cortex in Parkinson’s disease-related pain

MK. Lu, CM. Chen, SM. Liu, CH. Tsai (Taichung, Taiwan)
Cortical gamma oscillations in Parkinson’s disease: ipsi- and contralateral deep brain stimulation-induced entrainment

M. Shcherbakova, S. Cernera, A. Hahn, S. Little, P. Starr (San Francisco, USA)
Cortical mean diffusivity and cortical thickness in essential tremor

SY. Kang, E. Lee, P. Lee, M. Kim (Hwaseong, Republic of Korea)
Cortical mean diffusivity changes in Parkinson’s disease with probable RBD

J. Pardo, V. Montal, A. Campabadal, J. Oltra, C. Uribe, I. Roura, MJ. Martí, Y. Compta, A. Iranzo, J. Fortea, C. Junqué, B. Segura (Barcelona, Spain)
Cortical thickness and global atrophy progression in Parkinson’s disease with probable RBD

J. Oltra, A. Campabadal, C. Uribe, J. Pardo, I. Roura, MJ. Martí, Y. Compta, F. Valldeoriola, N. Bargallo, A. Iranzo, C. Junque, B. Segura (Barcelona, Spain)
Corticobasal Syndrome (CBS), Corticobasal Degeneration (CBD) and Progressive Supranuclear Palsy (PSP) Cohort in Central New York

M. Iqbal, T. Chabrashvili (Syracuse, USA)
Cost-effectiveness of Lee Silverman Voice Treatment LOUD (LSVT®) versus NHS Speech and Language Therapy versus control for dysarthria in Parkinson’s disease: An economic evaluation alongside the PD COMM trial

C. Clarke, Z. Abdali, S. Jowett, C. Rick, M. Brady, R. Woolley, C. Burton, S. Patel, P. Masterson-Algar, A. Nicoll, C. Smith, N. Ives, G. Beaton, S. Dickson, R. Ottridge, H. Nankervis, C. Sackley (Birmingham, United Kingdom)
Country and Sex Differences in Diagnosis Latency of Parkinson’s Disease in Latin American Populations

J. Ramchandra, M. Inca-Martinez, TP. Leal, E. Gatto, F. Micheli, BL. Santos-Lobato, F. Cardoso, G. Letro, P. Braga-Neto, V. Peixoto, AF. Schumacher-Schuh, C. Rieder, V. Tumas, V. Borges, P. Chana, P. Saffie, P. Olguin, A. Colombo, JL. Orozco Vélez, C. Velez-Pardo, M. Del Rio, A. Medina, M. Rodriguez-Violante, AJ. Hernandez-Medrano, D. Martinez-Ramirez, A. Ruiz-Contreras, A. Lazaro-Figueroa, P. Reyes, M. Cornejo-Olivas, AC. Medina Colque, JE. Rios Pinto, A. Viñuela, IF. Mata (Cleveland, USA)
Course of HIV-associated cerebellar ataxia on the background of antiretroviral therapy: clinical cases of 5 patients

L. Brsikyan, E. Nuzhnyi, е. Fedotova, S. Illarioshkin (Moscow, Russian Federation)
COVID-19 associated opsoclonus myoclonus ataxia syndrome

K. Petrosyan, L. Martirosyan, A. Papoyan, A. Ashughyan, S. Voskanyan (Yerevan, Armenia)
Creation of a biobank of patients with Progressive Supranuclear Palsy and Corticobasal Syndrome in Argentina

B. Couto, G. Mizraji, M. Maza, S. Sargiotto, F. Greloni, I. Paez Paz, E. Avale, T. Falzone (Buenos Aires, Argentina)
Creutzfeldt-Jakob Disease misdiagnosed as Corticobasal degeneration

M. Elkasaby, C. Duffy, B. Appleby (Cleveland, USA)
Crushing valbenazine capsule contents for potential addition to soft foods or administration via G tube

M. Hebert, A. Mar, R. Moore, A. Bristow, S. Siegert (San Diego, USA)
CSF tau reflects long-term outcome of patients with idiopathic normal pressure hydrocephalus: a longitudinal retrospective study.

J. Bissacco, C. Simonetta, D. Mascioli, N. Mercuri, T. Schirinzi (Roma, Italy)
Cued movement preparation and movement coding in human thalamic neurons

M. Baaske, A. Gulberti, A. Engel, M. Heise, W. Hamel, C. Gerloff, M. Pötter-Nerger, A. Sharott, C. Moll (Lübeck, Germany)
Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’

J. Lelaurin, R. Salloum, M. Okun (Gainesville, USA)
Curved Trajectories in Stereotactic Neurosurgery

A. Zemmar, J. Neimat, Y. Chitalia (Louisville, USA)
Custom-made Application Interface using Wacom® Tablet for Assessment of Writer’s Cramp

K V. Vysakha, VR. Radhakrishnan, PJ. James, SK. Krishnan, DK. K P (Trivandrum, India)